The drug, known as camizestrant, was authorised in an accelerated approval process and can be used in combination with other cancer medicines in patients who have a genetically-driven form of metastatic breast cancer.
The drug, known as camizestrant, was authorised in an accelerated approval process and can be used in combination with other cancer medicines in patients who have a genetically-driven form of metastatic breast cancer.
<iframe src="https://hindustansphere.com/embed/cluster/50eecd41710731fe5cf48829d8ecb7208b804aad" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="AstraZeneca's Breast Cancer Pill Gets Approval From The FDA"></iframe>
